XBiotech Inc
XBIT
Market Cap$219.64M
Close$
$6.57
12.4% downside
Current Fair Value
12.4% downsideOvervalued by 12.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $219.64 Million |
|---|---|
| Enterprise Value | $41.19 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.81 |
| Beta | 1.4 |
| Outstanding Shares | 30,456,101 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.27 |
|---|---|
| PEG | -12.86 |
| Price to Sales | - |
| Price to Book Ratio | 1.25 |
| Enterprise Value to Revenue | 15.72 |
| Enterprise Value to EBIT | -0.98 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About XBiotech Inc
CEO: John Simard